Acetyl octapeptide-3, a topical cosmetic SNAP-25-mimetic peptide
PRODUCT PROFILE
SNAP-8
£35.00
SNAP-8 is acetyl octapeptide-3, a topical cosmetic snap-25-mimetic peptide. Researchers examine it in relation to expression-line appearance and neuronal exocytosis models in skin.
Why it is distinct
A topical neurotransmitter-release-mimetic cosmetic peptide rather than a matrix-remodelling peptide.
- Evidence stageEarly human evidence
- AvailabilityUnavailable
- Batch recordPublished after verification
- DispatchConfirmed at checkout
Out of stock
Ask about availabilityPRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
SNAP-8 is acetyl octapeptide-3, a topical cosmetic snap-25-mimetic peptide. Researchers examine it in relation to expression-line appearance and neuronal exocytosis models in skin.
Research focus+
Researchers examine whether it can reduce signals involved in facial muscle contraction and soften the look of expression lines. Evidence is formulation-specific and much more limited than for established cosmetic treatments.
How the mechanism differs+
Designed to mimic part of SNAP-25 and modestly interfere with SNARE-complex formation in topical models.
Evidence and limitations+
Cosmetic formulation and small topical studies exist; it is not equivalent to botulinum toxin and systemic evidence is absent.
Testing and batch documentation+
No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.
RESEARCH PROFILE
Understand the distinction.
Researchers examine whether it can reduce signals involved in facial muscle contraction and soften the look of expression lines. Evidence is formulation-specific and much more limited than for established cosmetic treatments.
Designed to mimic part of SNAP-25 and modestly interfere with SNARE-complex formation in topical models.
A topical neurotransmitter-release-mimetic cosmetic peptide rather than a matrix-remodelling peptide.
Cosmetic formulation and small topical studies exist; it is not equivalent to botulinum toxin and systemic evidence is absent.
Educational research context only. This information is not dosage, administration or personal-use guidance.
CONTINUE EXPLORING
Related research perspectives.
Selected for useful comparison across neighbouring or contrasting research areas—not as combined-use guidance.
-
Early human evidence
Acetyl Tetrapeptide-3
£37.0010 mgBatch file pendingScalp/follicle matrix focus distinguishes it from SNAP-8’s expression-line mechanism and GHK-Cu’s copper biology.
UnavailableAsk about availability -
Early human evidence
Pal-GHK
£38.0010 mgBatch file pendingPalmitoylation—not copper binding—is the defining modification.
UnavailableAsk about availability -
Phase 2 clinical research
GHK-Cu
£24.99Batch file pendingGHK-Cu is a copper complex. Pal-GHK has a fatty tail for topical formulas, while non-copper peptides use different…
Available · 50 in stockAdd to basket -
Preclinical
AHK-CU
£40.99Batch file pendingAHK-CU uses the alanine–histidine–lysine sequence and has a narrower hair-follicle research record than the more widely studied GHK-Cu…
Available · 50 in stockAdd to basket